
Los nuevos anticoagulantes orales son una alternativa más para el tratamiento y la prevencion de la enfermedad tromboembólica, como su farmacología es nueva, aquí presentamos una revisión de los aspectos farmacológicos más importantes desde su dosificación, variaciones de acuerdo con las diferentes características de los pacientes, hasta los protocolos recomendados para cirugía y para intercambio de diferentes anticoagulantes, también las ventajas y contraindicaciones, así como algunas recomendaciones de antídotos. The new oral anticoagulants are an alternative for the treatment and prevention of thromboembolic disease, as its pharmacology is new, here is a review of the most important aspects from drug dosing and dose variations according to different patient, characteristics also present the recommended protocols for surgery and exchange of different anticoagulants benefits and contraindications as well as some recommendations of antidotes.
Epixaban, Endoxaban, Rivaroxaban, new oral anticoagulants, nuevos anticoagulantes orales, Dabigatran
Epixaban, Endoxaban, Rivaroxaban, new oral anticoagulants, nuevos anticoagulantes orales, Dabigatran
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
